Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel-cisplatin vs Docetaxel alone in elderly advanced NSCLC
NCT00190476Phase 3Terminated
- Sponsor
- Japan Clinical Oncology Group
- Start
- Apr 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin in non-small cell lung cancer (NSCLC), sponsored by Japan Clinical Oncology Group. Started Apr 2003; status: terminated.
02
Drugs
cisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00190476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00190476.